Semiparametric accelerated failure time cure rate mixture models with competing risks

被引:6
|
作者
Choi, Sangbum [1 ]
Zhu, Liang [2 ]
Huang, Xuelin [3 ]
机构
[1] Korea Univ, Dept Stat, 145 Anam Ro, Seoul 02841, South Korea
[2] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Houston, TX 77230 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77230 USA
基金
美国国家科学基金会;
关键词
competing risks; cure fraction; kernel smoothing; mixture model; nonparametric likelihood; subdistribution; EFFICIENT ESTIMATION; SURVIVAL-DATA; TRANSFORMATION MODELS; REGRESSION-ANALYSIS; CENSORED-DATA; INFERENCE; FRACTION;
D O I
10.1002/sim.7508
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Modern medical treatments have substantially improved survival rates for many chronic diseases and have generated considerable interest in developing cure fraction models for survival data with a non-ignorable cured proportion. Statistical analysis of such data may be further complicated by competing risks that involve multiple types of endpoints. Regression analysis of competing risks is typically undertaken via a proportional hazards model adapted on cause-specific hazard or subdistribution hazard. In this article, we propose an alternative approach that treats competing events as distinct outcomes in a mixture. We consider semiparametric accelerated failure time models for the cause-conditional survival function that are combined through a multinomial logistic model within the cure-mixture modeling framework. The cure-mixture approach to competing risks provides a means to determine the overall effect of a treatment and insights into how this treatment modifies the components of the mixture in the presence of a cure fraction. The regression and nonparametric parameters are estimated by a nonparametric kernel-based maximum likelihood estimation method. Variance estimation is achieved through resampling methods for the kernel-smoothed likelihood function. Simulation studies show that the procedures work well in practical settings. Application to a sarcoma study demonstrates the use of the proposed method for competing risk data with a cure fraction.
引用
收藏
页码:48 / 59
页数:12
相关论文
共 50 条